Pregnancy Outcomes in Patients Exposed to Intramuscular Interferon beta-1a (IM IFNβ-1a)

被引：0
|
作者：
Tomczyk, Sylvie [1 ]
Sperling, Bjorn [2 ]
机构：
[1] Biogen Idec Inc, Cambridge, MA USA
[2] Biogen Idec Inc, Weston, MA USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S30006
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis
    Cristina Guijarro
    Julián Benito-León
    Félix Bermejo-Pareja
    Neurological Sciences, 2011, 32 : 309 - 311
  • [32] Utilization and safety of intramuscular interferon beta-1a in the post-marketing setting
    Hyde, R.
    Curnow, K.
    Foulds, P.
    Richman, S.
    Friend, S.
    Glick, G.
    Onigman, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 493 - 493
  • [33] Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age
    Lampl, C.
    You, X.
    Limmroth, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (01) : 142 - 148
  • [34] A trial of interferon beta 1a (IFN beta 1a) for 4 weeks for therapy of acute hepatitis C.
    Lee, WM
    Shiffman, ML
    Gnann, JW
    Samanta, A
    Alam, J
    HEPATOLOGY, 1996, 24 (04) : 595 - 595
  • [35] Efficacy of daclizumab HYP versus intramuscular interferon beta-1a in patients without neutralising antibodies against interferon beta in the DECIDE study
    Bertolotto, A.
    Sorensen, P. Soelberg
    Ravnborg, M.
    Cohan, S.
    Wang, P.
    Fam, S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 287 - 288
  • [36] Efficacy and Safety of Weekly Intramuscular Interferon Beta-1a in Patients More Than 50 Years of Age
    Lampl, Christian
    Buffels, Regine
    Mair, Wolfgang
    You, Xiaojun
    Limmroth, Volker
    NEUROLOGY, 2010, 74 (09) : A542 - A542
  • [37] Efficacy and safety of interferon beta-1a for intramuscular injections biosimilar in patients with relapsing remitting multiple sclerosis
    Khabirov, F.
    Averianova, L.
    Babicheva, N.
    Dykhanov, A.
    Granatov, E.
    Khaybullin, T.
    Shakirzianova, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 446 - 447
  • [38] Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b
    Antonelli, G
    Simeoni, E
    Bagnato, F
    Pozzilli, C
    Turriziani, O
    Tesoro, R
    Di Marco, P
    Gasperini, C
    Fieschi, C
    Dianzani, F
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 168 (02) : 131 - 136
  • [39] Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis
    不详
    FORMULARY, 2002, 37 (04) : 169 - 169
  • [40] Stable multiple sclerosis patients on intramuscular interferon beta-1a therapy have better outcomes when staying on therapy than patients who switch to another interferon
    Cohan, S.
    Smoot, K.
    Kresa-Reahl, K.
    Kendter, J.
    Garland, R.
    Yeh, W. -S.
    Wu, N.
    Serafini, P.
    Watson, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 782 - 783
12345